Poor work outcomes in patients with spondyloarthritis: causes, consequences, and solutions.
Sick leave
Spondyloarthritis
Work
Work productivity
Journal
Clinical rheumatology
ISSN: 1434-9949
Titre abrégé: Clin Rheumatol
Pays: Germany
ID NLM: 8211469
Informations de publication
Date de publication:
Feb 2022
Feb 2022
Historique:
received:
09
06
2021
accepted:
01
09
2021
revised:
27
08
2021
pubmed:
8
10
2021
medline:
27
1
2022
entrez:
7
10
2021
Statut:
ppublish
Résumé
Spondyloarthritis (SpA) affects patients in the prime of their economic productivity and can cause loss of work productivity and unemployment. We aim to identify factors associated with poor work outcomes in patients with SpA. A cross-sectional study was performed in 100 patients with SpA who were employed, retired, or off work because of SpA. Data on sociodemographic and professional characteristics were collected as well as specific indices: BASDAI, ASDAS-CRP, BASFI, and BASMI. Work productivity in employed patients was assessed by the Work Productivity and Activity Impairment scale (WPAI:SpA). Patients were divided into 73 men and 27 women; the mean age was 43.68 ± 10.3 years. Fifty-nine percent of patients were employed and 26% were off work. The average disease duration was 12.24 ± 8.73 years. The mean BASDAI score was 4.4 ± 2.4, the average BASFI score was 4.6 ± 2.7, and the average ASDAS-CRP score was 2.77 ± 1.18. The mean BASMI was 4.4 ± 2.8. Among employed patients, the mean of absenteeism, presenteeism, and work productivity loss was 21.8 ± 33.13%, 42 ± 32%, and 46.5 ± 35.31%, respectively. In multivariable analysis, absenteeism was associated with ASDAS ≥ 2.1 (β = 20.14), peripheral joint involvement (β = 15.6), manual work (β = 14.31), low level of education (β = 7.92), and BASFI ≥ 4 (β = 6.39). Presenteeism and work productivity loss were associated with manual work, BASFI ≥ , body mass index ≥ 25 kg/m Spondyloarthritis affects work productivity. Screening for predictive factors should be considered by the clinician in the overall management of the disease. Key Points • SpA occurs among young and active patients; it could affect their professional lives and thus lead to loss of work productivity and unemployment. • The management of patients with SpA must be multidisciplinary; this includes assessing contextual factors in order to act on modifiable factors such as smoking and BMI, optimal management of the disease to maintain at least a low disease activity, and to ensure workstation layout and elimination of professional constraints that can affect work outcomes in patients with SpA.
Sections du résumé
BACKGROUND
BACKGROUND
Spondyloarthritis (SpA) affects patients in the prime of their economic productivity and can cause loss of work productivity and unemployment. We aim to identify factors associated with poor work outcomes in patients with SpA.
METHODS
METHODS
A cross-sectional study was performed in 100 patients with SpA who were employed, retired, or off work because of SpA. Data on sociodemographic and professional characteristics were collected as well as specific indices: BASDAI, ASDAS-CRP, BASFI, and BASMI. Work productivity in employed patients was assessed by the Work Productivity and Activity Impairment scale (WPAI:SpA).
RESULTS
RESULTS
Patients were divided into 73 men and 27 women; the mean age was 43.68 ± 10.3 years. Fifty-nine percent of patients were employed and 26% were off work. The average disease duration was 12.24 ± 8.73 years. The mean BASDAI score was 4.4 ± 2.4, the average BASFI score was 4.6 ± 2.7, and the average ASDAS-CRP score was 2.77 ± 1.18. The mean BASMI was 4.4 ± 2.8. Among employed patients, the mean of absenteeism, presenteeism, and work productivity loss was 21.8 ± 33.13%, 42 ± 32%, and 46.5 ± 35.31%, respectively. In multivariable analysis, absenteeism was associated with ASDAS ≥ 2.1 (β = 20.14), peripheral joint involvement (β = 15.6), manual work (β = 14.31), low level of education (β = 7.92), and BASFI ≥ 4 (β = 6.39). Presenteeism and work productivity loss were associated with manual work, BASFI ≥ , body mass index ≥ 25 kg/m
CONCLUSION
CONCLUSIONS
Spondyloarthritis affects work productivity. Screening for predictive factors should be considered by the clinician in the overall management of the disease. Key Points • SpA occurs among young and active patients; it could affect their professional lives and thus lead to loss of work productivity and unemployment. • The management of patients with SpA must be multidisciplinary; this includes assessing contextual factors in order to act on modifiable factors such as smoking and BMI, optimal management of the disease to maintain at least a low disease activity, and to ensure workstation layout and elimination of professional constraints that can affect work outcomes in patients with SpA.
Identifiants
pubmed: 34618257
doi: 10.1007/s10067-021-05904-3
pii: 10.1007/s10067-021-05904-3
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
463-470Informations de copyright
© 2021. International League of Associations for Rheumatology (ILAR).
Références
Taurog JD, Chhabra A, Colbert RA (2016) Ankylosing spondylitis and axial spondyloarthritis. N Engl J Med 374(26):2563–2574
doi: 10.1056/NEJMra1406182
Stolwijk C, Van Onna M, Boonen A, Van Tubergen A (2016) Global prevalence of spondyloarthritis: a systematic review and meta-regression analysis. Arthritis Care Res (Hoboken) 68(9):1320–1331
doi: 10.1002/acr.22831
Boonen A, Van Der Heijde D, Landewe R, Spoorenberg A, Schouten H, Rutten-van M et al (2002) Work status and productivity costs due to ankylosing spondylitis: comparison of three European countries. Ann Rheum Dis 61(5):429–437
doi: 10.1136/ard.61.5.429
Haglund E, Bremander A, Bergman S, Jacobsson LTH, Petersson IF (2013) Work productivity in a population-based cohort of patients with spondyloarthritis. Rheumatology 52:1708–1714
doi: 10.1093/rheumatology/ket217
Rodrigues Manica S, Sepriano A, Ramiro S, Pimentel Santos F, Putrik P, Nikiphorou E et al (2018) Work participation in spondyloarthritis across countries: analysis from the ASASCOMOSPA study. Ann Rheum Dis 77(9):1303–1310
doi: 10.1136/annrheumdis-2018-213464
Kchir MM, Ghannouchi M, Hamdi W, Azzouz D, Kochbati S, Saadellaoui K et al (2009) Impact of the ankylosing spondylitis on the professional activity. Joint Bone Spine 76(4):378–382
doi: 10.1016/j.jbspin.2008.08.010
Barlow JH, Wright CC, Williams B, Keat A (2001) Work disability among people with ankylosing spondylitis. Arthritis Rheum 45(5):424–429
doi: 10.1002/1529-0131(200110)45:5<424::AID-ART361>3.0.CO;2-7
Younes M, Jalled A, Aydi Z, Zrour S, Korbaa W, Salah Z et al (2010) Impact socioéconomique de la spondylarthrite ankylosante en Tunisie. Rev Rhum 77:49–54
doi: 10.1016/j.rhum.2009.11.016
Boonen A, Chorus A, Miedema H, Van Der Heijde D, Van Der Tempel H, Van Der Linden S (2001) Employment, work disability, and work days lost in patients with ankylosing spondylitis: a cross sectional study of Dutch patients. Ann Rheum Dis 60(4):353–358
doi: 10.1136/ard.60.4.353
Boonen A (2006) A review of work-participation, cost-of-illness and cost-effectiveness studies in ankylosing spondylitis. Nat Clin Pract Rheumatol 2(10):546–553
doi: 10.1038/ncprheum0297
White D, Lao C, Williams M, Lawrenson R, Dalbeth N (2019) The costs associated with ankylosing spondylitis/axial spondyloarthritis in Aotearoa/New Zealand. N Z Med J 132(1505):38–47
pubmed: 31697662
Merino M, Braçe O, González-Domínguez A, Hidalgo-Vega Á, Garrido-Cumbrera M, Gratacós J (2021) Social economic costs of ankylosing spondylitis in Spain. Clin Exp Rheumatol 39(2):357–364
pubmed: 32662412
Boonen A, Van Der Heijde D, Landewe R et al (2003) Costs of ankylosing spondylitis in three European countries: the patient’s perspective. Ann Rheum Dis 62(8):741–747
doi: 10.1136/ard.62.8.741
Ward MM (2002) Functional disability predicts total costs in patients with ankylosing spondylitis. Arthritis Rheum 46(1):223–231
doi: 10.1002/1529-0131(200201)46:1<223::AID-ART498>3.0.CO;2-#
Yi E, Ahuja A, Rajput T, George AT, Park Y (2020) Clinical, economic, and humanistic burden associated with delayed diagnosis of axial spondyloarthritis: a systematic review. Rheumatol Ther 7(1):65–87
doi: 10.1007/s40744-020-00194-8
Rudwaleit M, Van Der Heijde D, Landewe R, Listing J, Akkoc N, Brandt J et al (2009) The development of Assessment of SpondyloArthritis international Society classification criteria for axial spondyloarthritis (part II): validation and final selection. Ann Rheum Dis 68(6):777–783
doi: 10.1136/ard.2009.108233
Rudwaleit M, Van Der Heijde D, Landewe R, Akkoc N, Brandt J, Chou CT et al (2011) The Assessment of SpondyloArthritis International Society classification criteria for peripheral spondyloarthritis and for spondyloarthritis in general. Ann Rheum Dis 70(1):25–31
doi: 10.1136/ard.2010.133645
Boonen A, Boone C, Albert A, Mielants H (2015) Understanding limitations in at-work productivity in patients with active ankylosing spondylitis: the role of work-related contextual factors. J Rheumatol 42(1):93–100
doi: 10.3899/jrheum.131287
Garrett S, Jenkinson T, Kennedy LG, Whitelock H, Gaisford P, Calin A (1994) A new approach to defining disease status in ankylosing spondylitis: the Bath Ankylosing Spondylitis Disease Activity Index. J Rheumatol 21(12):2286–2291
pubmed: 7699630
Calin A, Garrett S, Whitelock H, Kennedy LG, O’Hea J, Mallorie P et al (1994) A new approach to defining functional ability in ankylosing spondylitis: the development of the Bath Ankylosing Spondylitis Functional Index. J Rheumatol 21(12):2281–2285
pubmed: 7699629
Jenkinson TR, Mallorie PA, Whitelock HC, Kennedy LG, Garrett SL, Calin A (1994) Defining spinal mobility in ankylosing spondylitis (AS). The Bath AS Metrology Index. J Rheumatol. 21(9):1694–8
pubmed: 7799351
Lukas C, Landewe R, Sieper J, Dougados M, Davis J, Braun J et al (2009) Development of an ASAS-endorsed disease activity score (ASDAS) in patients with ankylosing spondylitis. Ann Rheum Dis 68(1):18–24
doi: 10.1136/ard.2008.094870
Reilly MC, Gooch KL, Wong RL, Kupper H, van der Heijde D (2010) Validity, reliability and responsiveness of the Work Productivity and Activity Impairment Questionnaire in ankylosing spondylitis. Rheumatology (Oxford) 49(4):812–819
doi: 10.1093/rheumatology/kep457
Goh Y, Kwan YH, Leung YY, Fong W, Cheung PP. A cross-sectional study on factors associated with poor work outcomes in patients with axial spondyloarthritis in Singapore. Int J Rheum Dis. 2019;22(11):2001–8.
Coates LC, Orbai AM, Morita A, Benichou O, Kerr L, Adams DH et al (2018) Achieving minimal disease activity in psoriatic arthritis predicts meaningful improvements in patients’ healthrelated quality of life and productivity. BMC Rheumatol 2:24
doi: 10.1186/s41927-018-0030-y
Tran-Duy A, Nguyen TT, Thijs H, Baraliakos X, Heldmann F, Braun J et al (2015) Longitudinal analyses of presenteeism and its role as a predictor of sick leave in patients with ankylosing spondylitis. Arthritis Care Res (Hoboken) 67(11):1578–1585
doi: 10.1002/acr.22655
Maksymowych WP, Gooch KL, Wong RL, Kupper H, Van Der Heijde D (2010) Impact of age, sex, physical function, health-related quality of life, and treatment with adalimumab on work status and work productivity of patients with ankylosing spondylitis. J Rheumatol 37(2):385–392
doi: 10.3899/jrheum.090242
Boonen A, Brinkhuizen T, Landewe R, Van Der Heijde D, Severens JL (2010) Impact of ankylosing spondylitis on sick leave, presenteeism and unpaid productivity, and estimation of the societal cost. Ann Rheum Dis 69(6):1123–1128
doi: 10.1136/ard.2009.116764
Van Der Weijden MA, Boonen A, Van Der Horst-Bruinsma IE (2014) Problems in work participation and resource use should not be underestimated in patients with early spondyloarthritis. J Rheumatol 41(12):2413–2420
doi: 10.3899/jrheum.140396
De Hooge M, Ramonda R, Lorenzin M, Frallonardo P, Punzi L, Ortolan A et al (2016) Work productivity is associated with disease activity and functional ability in Italian patients with early axial spondyloarthritis: an observational study from the SPACE cohort. Arthritis Res Ther 18(1):265
doi: 10.1186/s13075-016-1162-3
Stolwijk C, Castillo Ortiz JD, Gignac M, Luime J, Boonen A, OMERACT Worker Productivity Group. Importance of contextual factors when measuring work outcome in ankylosing spondylitis: a systematic review by the OMERACT worker productivity group. Arthritis Care Res (Hoboken). 2015;67(9):1316–27.
Zhao SS, Nikiphorou E, Boonen A, López-Medina C, Dougados M, Ramiro S (2021) Association between individual and country-level socioeconomic factors and work participation in spondyloarthritis including psoriatic arthritis: analysis of the ASAS-perSpA study. Semin Arthritis Rheum 51(4):804–812
doi: 10.1016/j.semarthrit.2021.05.020
Nikiphorou E, Boonen A, Fautrel B, Richette P, Landewé R, Van der Heijde D, et al. How do clinical and socioeconomic factors impact on work disability in early axial spondyloarthritis? Five-year data from the DESIR cohort. Rheumatology (Oxford). 2021:keab607.
Van Lunteren M, Ez-Zaitouni Z, Fongen C, Landewe R, Ramonda R, van der Heijde D et al (2017) Disease activity decrease is associated with improvement in work productivity over 1 year in early axial spondyloarthritis (SPondyloArthritis Caught Early cohort). Rheumatology (Oxford) 56(12):2222–2228
doi: 10.1093/rheumatology/kex365
Macfarlane GJ, Shim J, Jones GT, Walker-Bone K, Pathan E, Dean LE (2019) Identifying persons with axial spondyloarthritis at risk of poor work outcome: results from the British Society for rheumatology biologics register. J Rheumatol 46(2):145–152
doi: 10.3899/jrheum.180477
Grazio S, Jajic Z, Nemcic T, Jajic I (1997) Work capacity evaluation in patients with ankylosing spondylitis. Reumatizam 45(2):1–5
pubmed: 9769720
Guillemin F, Briançon S, Pourel J, Gaucher A (1990) Long-term disability and prolonged sick leaves as outcome measurements in ankylosing spondylitis. Possible predictive factors Arthritis Rheum 33(7):1001–1006
pubmed: 2369416